LIVER DISEASES

normal anatomy

  • average weight 1.5 kg
  • subdivided into lobes and sections
  • vascular supply is important for surgical supply

the vascular supply is part
of the splachnic circulation

three main vessels

coeliac trunk (left gastric artery, common hepatic artery, splenic artery), superior mesenteric artery and inferior mesenteric artery

major veins draining to the liver
through the portal vein

esophageal vein, right and left gastric veins, splenic vein, inferior and superior mesenteric veins

â…” of the flow arriving to the liver comes from the portal vein

this blood contains oxygen and many nutrients brought to the liver from the intestines for processing

the liver receives both oxygenated (from the hepatic artery) and partially deoxygenated blood (from the portal vein)

the blood mixes in the sinusoids, being then collected in the central vein, which drains into the hepatic vein and subsequently into the inferior vena cava

histologically and microscopically, the liver is divided into two functional units

LOBULE

ACINUS

hexagonal structure with the portal system at the periphery and a central/terminal hepatic vein at the centre

in the middle there are cords of hepatocytes radiating out, extnding to the portal triads

portal triads consist of branches of the hepatic artery and of the portal vein, together with bile ducts

parenchymal area arranged around an arteriole, a terminal venule and an interlobular biliary ductule, lying between two centrilobular veins

at the centre of the acinus there is the portal system and the central vein is at the apical part of the acinus

zones

  • zone 1: near the portal system, entrance of oxygenated blood from hepatic arteries
  • zone 2: intermediate
  • zone 3: around the central vein and poorly oxygenated compared to the other two zones

at the microscope

lobules have an hexagonal form

beyond the portal system, there is a line of hepatocytes ("peripheral lamina")

it consists of a single lamina of hepatocytes which serves as a parameter to evaluate whether an inflammation is active or not

during an active inflammatory status, there is an infiltration of lymphocytes

when the lamina is intact, it limits the infilration of other cells

acini have a triangular shape, with the portal triad at its base and with the central vein at the apex

this structure can be affected by congestion,
e.g. in the case of right heart failure

the liver architecture is sustained by reticles, which represent the cytoskeleton of the liver (single-row trabeculae of hepatocytes)

in the presence of more than one row of hepatocytes in the reticle, this may be due to regeneration, neoplastic transformation or cirrhotic events

liver biopsy

high risk of hemorrhage due to the high vascularizatio of the liver (thus, rarely performed)

indications

  • positive lab tests (elevated ALT, AST) for liver damage
  • presence of specific/generic suspicious signs and symptoms (e.g. jaundice, fever)
  • confirmation of clinical diagnosis
  • follow up of patients with known liver disease
  • diagnosis of a "focal lesion" nature, i.e. a liver mass at imaging

evaluation scheme

general architecture

evaluate if it is preserved of if altered by specific processes

  • the liver should be subdivided into its different units
  • the central vein must be a the centre, while in the periphery there must be the portal vein
  • check the limiting lamina of hepatocytes
  • there should be one single row of hepatocytes forming the parenchyma, which should be divided by the sinusoids
  • the reticulum should be thin

portal spaces

check if they are well distributed or affected by inflammation, ductular proliferation or limiting lamina

centrilobular vein status

sometimes it can be affected by fibroisis, limiting blood flow

processes altering the general architecture

INFLAMMATION

it is important to understand the location of the inflammatory process

portal inflammation

chronic cholangitis, typical of primary biliary cirrhosis

intralobular inflammation

through hepatocytes, typical of acute forms of hepatitis, lymphocytic

graulocyte inflammation

mostly biliary, vasculitic or
in alcoholic hepatitis

granulomas

a possible cause is sarcoidosis
(NOT TUBERCULOSIS)

aka "hepatitis of the interface"

either granulocytic (ACUTE)
or lymphocytic (CHRONIC)

in a chronic condition it is important to look at the status of the periportal lamina

the invasion of the lymphocytes induces the necrosis of the hepatocytes of the peri-portal lamina
(typical in chronic conditions)

PERIPOLESIS/HEMPERIPOLESIS
(or "piecemeal necrosis")

FIBROSIS

periportal (around the lobules)

peri-centrolobular (aka periterminal)

bridge

sign of portal hypertension or heart failure

complet disruption of the lobules, hepatocytes necrosis with fibrotic deposition inside the cells, followed by a sort of nodular regeneration and the formation of bridges

typical of cirrhosis

ATROPHY

  • pretty rare event
  • generally coming from inanition or senility
  • the stroma prevails everywhere with an increased consistency, in spite of hepatocytes which become progressively thinner
  • at microscopy, the liver appears brown due to a profuse secretion of lipofuscin pigment into the cytoplasm of the hepatocytes
    --> "BROWN ATROPHY"

elementary lesions of hepatocytes

BALLOONING DEGENERATION

commonly seen in hepatitis, in particular NASH and HBV

cellular enlargement 1.5-2x the normal hepatocyte diameter, with rarefied cytoplasm

hepatocytes become white and ballooned

STEATOSIS

accumulation of fat in hepatocytes

hepatocytes show clear big lobules in their cytoplasm (macrovesicular) or microvesicles

quite common condition, caused by bad dietary habits, alcoholic hepatitis, NAFLD and NASH

MALLORY BODIES

eosinophilic amorphous material derived from the haptocytes cytoskeleton, accumulating in their cytoplasm

nonspecific finding

DD: hepatitis B/C, alcoholic/nonalcoholic fatty liver, HCC, PBC, chronic cholestasis, focal nodular hyperplasia, Wilson disease and copper toxicosis

COUNCILMAN-EOSINOPHILIC BODIES

signs of apoptotic death of single shrink, losing their normal size

typically caused by viral infections (yellow fever)

GROUND GLASS CYTOPLASM OF HEPATOCYTES

alteration caused by proliferation of the endoplasmic reticulum, easily recognizable, characterized by the binucleation of hepatocytes

a possible cause is chronic hepatitis B

CHOLESTASIS or FEATHERY DEGENERATION

accumulation of bile inside the cells with flocculant appearing cytoplasm (full of yellow round spots)

hepatocytes appear larger than normal

on the basis of the etiology, cholestasis may be intrahepatic or intravascular

GLYCOGENOSIS OF THE NUCLEI

especially observed in diabetes

hepatocyte nuclei appear completely empty, like rings

tumors

non-neoplastic liver diseases

HEPATITIS

  • inflammation of the liver tissue
  • either acute or chronic

ACUTE HEPATITIS

etiology

  • hepatotropic viruses (A,B, C, delta, etc.)
  • non-hepatotropic viruses (paramyxovirus, EBV, CMV, HSV)
  • drugs
  • alcohol-related, inducing acute hepatitis
  • immunologic/inflammatory conditions
  • metabolic or hereditary
  • pregnancy-related
  • ischemic and vascular diseases
  • misclellaneous/mixed

at core biopsy

  • portal triad assessment
  • eventual periportal inflammation and nature of inflammatory infiltrate (granulocytes or lymphocytes)
  • liver parenchyma status must be checked, along with sinusoids
  • look for the presence of the typical elementary lesions of acute hepatitis at the liver (necrosis, apoptosis, cholestasis, steatosis, ballooniform degeneration)

biopsy is more frequently asked in forms of post acute hepatitis (upon healing), to check if the inflammatory process is truly over

effects of past necrosis:

  • hepatocyte regeneration in a not-so-well organized form (mitotic cells, hepatocytic arrangement in two rows or pseudo-acini)
  • collapse of reticular fibers due to fibrotic deposition, macrophage cells with PAS-d+ pigment
  • bilirubinostasis - cholstasis

DRUG ACUTE HEPATITIS

  • the effect of drugs on the liver is dose-dependent
  • it may be idiosynchratic
  • etiology: mixed, mainly toxic or metabolic
  • pathological findings: massive panacinar necrosis, apoptosis (cell debris and Kupffer hypertrophy), very scarce lymphocyte infiltrate, ductulogenesis, minimal hepatocyte regeration

CHRONIC HEPATITIS

duration

laboratory or symptom alteration >6 months

etiology

HBV

HCV

the inflammation starts within the portal system and it may go through the lobules, induce apoptosis, infiltration of lymphocytes and transformation of cells

in hepatitis C, a fatty transformation (steatosis)

in hepatitis B, ground glass appearance

  • ground glass cytoplasm cores with sandblasted appearance
  • hepatocytic "dysplasia" (large nucleoli and binucleation)
  • marked periportal inflammatioin with lymphocytes and plasma cells --> disruption of the lamina because of entrance of lymphocytes with necrosis
  • piecemeal necrosis of the hepatocytes because lymphocytes enter in the lobules

in the advanced stage, the necrotic status is progressively worse and progressively substituted by fibrotic deposition with bridge formation (from central vein and portal triad) and evolution into cirrhosis

in severe chronic active hepatitis, the inflammatory infiltrate expands into the liver parenchyma, destroying it

specific findings

  • mild activity, formation of lymphatic follicles
  • marked apoptosis (Councilman-eosinophilic bodies)
  • steatosis
  • presence of iron inside the hepatocytes

mixed pictures

  • signs of viral infection associated with features of alcoholic disease or autoimmune disease
  • increased inflammatory component and possibly marked steatosis

virus delta

always marked activity

grading and staging

ISHAK GRADING

based on the limiting (peripheral) and intra-acinar lamina necrosis and inflammation

if these structures are compromised, the grade of inflammation is higher

ISHAK STAGING

essentially based on fibrosis

among the different forms, the portal-central vein fibrosis is the worst one

other infective causes

HEPATIC ABSCESSES

mostly in the right lobe

  • blood from superior mesenteric and portal veins
  • it contains a denser network of biliary canaliculi and accounts for more hepatic bacterial infections
  • favored by immunosuppressive conditions
  • to be recognized and treated, otherwise fatal

ECHINOCOCCOSIS

it manifests as a unilocular cyst with opalescent content that can be already recognized by US
(highly indicative is also peripheral eosinophilia)

at the histological examination this cyst is thicker at the periphery due to an inflammatory and fibrous reaction of the host, while inside the cysts, there is a broad capsule - also called membrana proligera - where the schistosoma grows

the structure is surrounded by pink amorphous chitinous material

TOXIC and METABOLIC LIVER DISEASES

  • alcoholic liver diseases
  • non-alcoholic liver diseases
  • hemochromatosis
  • Wilson disease
  • alpha1 antitrypsin mutants

ALCOHOLIC HEPATITIS

  • alcohol has a dose-dependent effect, which is also influenced by age, sex and race
  • this condition may regress upon the complete interruption of alcohol consumption
  • alterations of the liver parenchyma are specific and highly indicative

elementary lesions

  • STEATOSIS: also seen at US and PET; macrivesicular up to rupture of membranes, formation of lipogranuloma
  • HEPATITIS: Mallory bodies, hepatocyte necrosis and neutrophilic granulocytes

NON-ALCOHOLIC FATTY
LIVER DISEASE (NAFD)

  • the most frequent liver disease
  • accumulation of liver fat
  • increase in liver weight of >5% in the presence of <10% of daily alcohol consumption
  • it may evolve into non-alcoholic steato-hepatitis

clinical manifestations are frequently associated with obesity, DMII

ccumulation of lipids into the liver causes lipotoxicity along with activation of the innate immune system

lipid-induced hepatocyte sub-lethal and lethal stress

liver biopsy is frequently requested

check disease activity

on the basis of steatosis/ballooning and lobular inflammation

check fibrous stage

the evolution is similar to the one induced by the alcoholic disease, from simple steatosis (NAFLD), to inflammation and necrosis (NASH), to fibrosis and cirrhosis

the cirrhotic status can eventually evolve into HCC

HEMOCHROMATOSIS

  • hereditary disease transmitted as an autosomal trait
  • caused by mutations of different genes, e.g. HAMP, that affect any of the proteins limiting the entry of iron into the blood
  • the consequence is an uncontrolled iron absorption

normal iron-driven erythropoiesis, with toxic accumulation of iron in parenchymal cells of the liver (cirrhosis), heart (cardiomyopathy) and endocrine glands (hypogonadism, DM, arthropathy and skin pigmentation)

at H&E:

lots of dark deposits around the central vein and in the portal space (Prussian blue staining)

hemosiderin is first deposited in the periportal area

hepatocytes affected die and are progressively substituted by fibrotic material, eventually leading to cirrhosis development

WILSON'S DISEASE

  • AR genetic disease
  • accumulation of toxic levels of copper in various organs, i.e. liver, brain, eyes, kidneys
  • there are also forms of intoxicarion from copper due to excessive exposition, leading to transitory neurological symptoms

at the hepatic level

reduced excretion of copper in the bile and failure to incorporate copper into cerulo-plasmin

liver lesions range from modest to massive

ALPHA1 ANTITRYPSIN DEFICIENCY

  • AAT protein is synthesized by the liver, then secreted into the serum
  • it inhibits neutrophil proteases
  • the mutant Z gene of AAT causes the synthesis of a mutant protein, which is retained intracellularly, rather than efficiently secreted, causing liver injury and triggering a cascade of chronic hepatocellular apoptosis, regeneration and end-organ damage (followed by cirrhosis and HCC)
  • the lungs may develop panacinar emphysema
  • at H&E, PINK INCLUSIONS (retained mutant proteins)
    --> globular PAD-d+ inclusions
  • IHC: specific anti-AAT antibodies

CHOLESTASIS

it is a consequence of intrahepatic deposition of conjugated bilirubin, also leading to hepatocellular damage

causes:

  • viral hepatitis
  • alcohol (ethanol metabolites-related damage; alcohol's effect on bile acid uptake and secretion)
  • NASHD
  • NASH
  • drug-induced liver injury
  • ischemic hepatitis
  • genetic hepatic disease (Wilson's disease, hemochromatosis)
  • primary or metastatic liver cancer

gallbladder hypomotility may cause altrations in the bilirubin cycle

  • alteration in the kinetics of the enterohepatic circulation of bile acids ( --> excessive cholesterol absorption, reduced bile acid absorption)
  • cholesterol nucleation and crystallization; gallbladder retainment of solid plate-like cholesterol monohydrate crystals (stones formation)

elementary lesions

  • bilirubinostasis and biliary thrombi
  • portal edema
  • portal ductular proliferation with granulocyte infiltrate
  • hepatocyte degeneration in the vicinity of biliruin deposits
  • bridging fibrous septae with evolution into cirrhosis

major problem in the context of cholestasis: possible evolution into a form of cholangitis

CHOLANGITIS

ACUTE INFECTIVE CHOLANGITIS

in case of biliary obstruction:

  • bile becomes stagnant in the biliary system
  • the intraductal pressure increases
  • the tight junctions between cholangiocytes widen
  • Kuppfer cells undergo malfunctioning
  • the production of IgA decreases

bacteria invade more easily the liver parenchyma causing an acute infective cholangitis

etiologies

  • E. coli
  • Klebsiella spp
  • Enterococcus spp
  • Enterobacter spp

histology

consistent amount of granulocytes, causing inflammation and damage of hepatic parenchyma

CHRONIC PRIMARY CHOLANGITIS

difficult to diagnose as it may mimic different entities, e.g. HCC

clinical presentations

PBC

  • intrahepatic ducts (intralobular bile ducts)
  • F>M
  • etiology: AI, AMA, ANA
  • histology: early portal inflammatory stage, demonstrating granulomatous features; inflammatory infiltrate of lymphocytes and plasma cells; large roundish portal systems with complete disruption of the bile ducts
  • therapy: UDCA + anticholestatic and antifibrotic effects
  • prognosis: variable

PSC

  • intrahepatic and/or extrahepatic ducts
  • F<M
  • etiology: idiopathic (HLA?, IBD?)
  • histology: predominant fibrosis at different parts of the biliary tract, periductal concentric "onion skin" fibrosis and stricturing
  • therapy: no effective therapy other than LT
  • prognosis: possible evolution into different hepatobiliary cancers

CIRRHOSIS

histology

  • fibrous bands that disrupt the hepatic parenchyma
  • fibsoris-sequestration-regeneration (micro-macronodular)
  • defects of microcirculation with venous shunts and arterial hypoperfusion, increased vascular resistance

local and systemic complications

  • portal hypertension (varices, ascites)
  • deficiency pf protein synthesis and detoxification
  • liposoluble vitamin deficiencies (A, D, E, K)
  • bleeding disorders
  • bone disorders
  • hepatic encephalopathy
  • renal dysfunction (hepato-renal syndrome)
  • lung dysfunction (hepato-pulmonary syndrome)
  • evolution to HCC
  • portal thrombosis

PATHOPHYSIOLOGY of
PORTAL HYPERTENSION

  1. cirrhosis leads to pronounced hepatic microvascular changes, as the fibrotic process causes defects of microcirculation along with increased vascular resistance
  • sinusoidal remodelling (ECM deposition from proliferating activated stellate cells, resulting in capillarisation of hepatic sinusoids)
  • formation of intrahepatic shunts (due to angiogenesis and loss of parenchymal cells) and consequent arterial hypoperfusion
  • hepatic endothelial dysfunction with hepatocyte damage
  1. the resulting increased hepatic resistance determines an increasing portal pressure

onset of portal hypertension

consequences

  • varices --> at the level of the esophageal tract and stomach
  • hypertensive gastropathy
  • spleen congestion, hemorrhoids, cput medusae
  • ascites (>50% od cirrhotic patients)

ascites may be complicated by spontaneous bacterial peritonitis (due to bacterial translocation from enteric origin)

HEPATORENAL SYNDROME

liver dysfunction may lead to acute kidney injury

systemic vasodilation

reduction in the effective arterial blood volume and systemic arterial pressure

activation of anti-natriuretic system and RAAS system

cirrhotic cardiomyopathy

systemic inflammation

also the adrenal gland may get involved
(hepato-adrenal syndrome)

the increased secretion of aldosterone causes an increased Na+ and H2O reabsorption at
the level of the distal tubules

cholemic nephropathy may arise

caused by the formation of obstructing intratubular bile acid casts at the level of the kidneys

bile at the level of the kidneys is able to exert a direct acid toxic effect on tubular cells

intra-abdominal hypertension

types

type 1

rapidly progressive

leading to kidney failure in less than 2 weeks

type 2

slower course
(weeks/months)

HEPATIC ENCEPHALOPATHY

brain dysfunction caused by liver failure and/or portal systemic blood shunting

neurological/psychiatric abnormalities, ranging from subclinical alterations to coma

main cause: HYPERAMMONEMIA

this leads to the increase in the levels of inflammatory cytokines, causing BBB damage

HEPATOPULMONARY SYNDROME
and ARTERIAL HYPOXEMIA

lung dysfunction correlates with a cirrhotic status

the production of endotoxins and TNF alpha may induce the onset of intrapulmonary vasodilation, angiogenesis and shunt formation

consequence:
pulmonary hypertension and loss of alveolar type II cells
(HYPOXEMIA)

HEPATOCARCINOMA

difficult to be diagnosed because the cirrhotic changes of the hepatocytes are already similar to the ones seen in neoplastic transformation

frequent cause of death in cirrhotic patients

PORTAL THROMBOSIS

  • partial or complete
  • found in cirrhotic pts with concomitant HCC
  • increase in pressure in the portal vein with possible rupture of esophageal varices and ascites

PORTAL HYPERTENSION

NOT ONLY CAUSED BY CIRRHOSIS

causes

suprahepatic

constrictive pericarditis, righ heart failure, IVC thrombosis, Budd-Chiari syndrome, veno-occlusive disease

intrahepatic

sinusoidal

cirrhosis, chronic acute hepatitis, alcoholic hepatitis, fatty liver

perisinusoidal

schistosomiasis, primary biliary cirrhosis, sarcoidosis, myeloproliferative diseases, nodular regenerative hyperplasia

intrahepatic

portal vein thrombosis, splenic vein thrombosis

from increased hepatic blood flow

hepatic arteriovenous fistula, conditions associated with massive splenomegaly

VENO-OCCLUSIVE FORM

at the level of hepatic sinusoids and terminal venules

etiology

sinusoidal endothelial injury, due to HSCT, CT, abdominal RT and pyrrolizidine alkaloids

histology

not a thrombosis of the central vein, rather an occlusion due to concentric subendothelial thickening

fibrosis around the central vein

BUDD-CHIARI SYNDROME

involvement of hepatic veins up to the superior end of IVC

induced by hepatic venous thrombosis, inducing hypoxic damage to the hepatocytes (along with possible IVC webs), due to compression of hepatic veins or IVC by tumor, cyst or abscess

CONGESTIVE HEPATOPATHY

from an increase in the right atrial pressure

congenital heart failure

CAD, cardiomyopathies, valve abnormalities

cor pulmonale

COPD, ILD, pulmonary HTN

pericardial disease

constrictive pericarditis, pericardial tamponade

absence of valves in the hepatic veins allows:

increased inferior caval pressure

centrilobular congestion

it may develop into a CHRONIC CONGESTIVE HEPATOPATHY

  • sinusoidal dilation and perivascular fibrosis
  • centrilobular liver cell necrosis (from the central vein, then extending to peripheral areas)
  • deposition and spread of connective tissue (with fibrotic processes substituting the parenchyma)
  • bridging one central vein to the other
  • cirrhosis

liver appears heavy and very consistent (hard) at the US

histology

NUTMEG APPEARANCE

typical of chronic passive congestion

in cases of acute decrease in cardiac output, there may be a form of acute cardiogenic ischemic hepatitis

NODULAR LESIONS

TUMOR-LIKE LESIONS

solitary cysts

  • F/M = 5/1
  • 2.5% population

polycystic liver

similar in appearance to solitary cysts, but multiple, hereditary and often associated with PCKD

multiple micro-amartomatosis

  • lesions simulate small metastases
  • mostly asymptomatic
  • F>M
  • von Meyenburg comples
  • agglomerations of malformed ducts

congenital hepatic fibrosis

  • AR
  • typical of adolescents and young adults with portal hypertension
  • proliferation of fibrous tissue and small ducts with enlargement of portal spaces

Caroli's disease

  • AR
  • segmental dilation of the biliary branches with dense bile and stones
  • sometimes portal hypertension

FOCAL HEPATIC NODULAR HYPERPLASIA

  • second most frequent benign liver nodule (after hemangioma)
  • a current hypothesis is that the primary lesion is an outflow obstruction and the resulting congestive injury leads to parenchymal collapse and fibrosis, arteriovenous shunting and loss of portal veins and ducts

pale, firm, well-delineated, lobulated, roundish and unencapsulated mass

the lesion is composed of nodules 2-3 mm in size, separated by zones of fibrosis that give the lesion a multinodular appearance

central stellate fibrous scar with radiating extensions that partially surround nodules

histology

fibrous septa searate hepatocellular nodules of different size, resempling cirrhosis

HEPATOCELLULAR ADENOMA

85% of HCAs occur in women of childbearing age

populations at risk:

  • women taking oral contraceptives (duration of usage, reversible)
  • men using anabolic steroids

LIVER - benign

ANGIOMA

ADENOMA of the BILE DUCTS

  • proliferation of the bile ducts at the level of the portal tracts
  • lesions can be single or multiple
  • grayish in complexion
  • micro: bile ducts proliferating in more or less dense connective tissue
  • DD: adenocarcinoma
  • most frequent tumor of the liver
  • affecting both sexes at all ages
  • often diagnosed at the core biopsy
  • the cavernous form is the one most frequently observed
  • angiomas can be single or multiple
  • high risk of rupture and bleeding

LIVER - malignant

HEPATOCELLULAR CARCINOMA

frequently arising from cirrhotic liver, but it can also appear in non-cirrhotic hepatic conditions

etiology

  • HBV/HCV infection
  • cirrhosis
  • carcinogens
  • genetic conditions (hemochromatosis and alpha1 antitrypsin deficiency)

diagnosis

CT with contrast

increase in AFP in serum

core biopsy for definitive diagnosis

histological diagnosis

pretty straightforward

sometimes, it may look similar to normal liver parenchyma affected by minor non-neoplastic alterations, such as infections

pathology

macro

single mass (>10 cm) or multiple masses (multifocal), lardaceous, irregular margins, greenish-yellow

micro

various patterns associated with Edmonson grading

  • G1 (well differentiated): of trabecular type with little atypia
  • G2 (intermediate differentiated): of pseudoglandular type with greater atypia
  • G3 (poorly differentiated) or G4 (undifferentiated): with various extensions of pleomorphic, spindle or giant cells

IHC

AFP, canalicular CEA, CK8-18 (CK19 neg), glipican 3, hepar 1

varieties

clear cell

F>M

fibrolamellar

  • distinguished by age (20-40y)
  • lack of typical risk factors of HCC
  • well-differentiated form with marked deposition of fibrous tissue

diffusion

  • to the portal vein thrombosis
  • by contiguity (rarely, hilar LNs)
  • distant metastases

prognosis

bad, even with different therapies; here is a good survival only in case of very well differentiated forms

complications

cachexia, ruptured esophageal varices liver failure

staging

number of nodes, tumor diameter, vascular invasion, affeced lobes

tumors of the bile ducts

INTRAHELATIC CHOLANGIOCARCINOMA

  • 10% of the primitive liver tumors
  • one of the main tumors to be related with CUP syndrome
  • diffuse metastases
  • etiology: use of Thorotrast, intrahepatic biliary parasites, HBV, smoking, alcohol, biliary tree anomalies
  • macro: withish, usually single, no bile content, sometimes copious mucus
  • micro: mucinous regions are indicative, well glandular differentiation, richness in fibrous stroma
  • very aggressive, bad prognosis
  • lymphatic and henatogenous spread
  • DD: ACC with metastases in liver and primary cholangiocarcinoma

HEPATOBLASTOMA

rare, childhood age (90% <5aa), rapidly growing abdominal mass, increased AFP, rare HCG production, at microscopy there are embryonic features

ANGIOSARCOMA

rare, associated with the use of thorotrast, PVC monomer or arsenic

LEUKEMIA and LYMPHOMA

METASTASES

  • most frequent tumors in the liver
  • origin can be via hepatic artery or portal vein
  • mostly multiple
  • good chances of remission after surgical treatment (recommended only in the presence of single lesions)

extrahepatic tumors

GALBLADDER TUMORS

carcinoma of the gallbladder

  • association with lithiasis or infections
  • macro: mostly in the collar, infiltrating or exophytic appearance with different histotypes
  • micro: histotype prevalent adenocarcinoma (papillary, mucinous, clear cells), but also squamous, adenosquamous or carcinoid

benign tumors

rare adenoma, papilloma, adenomyoma

EXTRAHEPATIC BILIARY TRACT CARCINOMA

  • rare, affecting mostly elderly males, pretty aggressive
  • causes: lithiasis, sclerosing cholangitis or infections
  • macro: stenosing lesion, small (early jaundice)
  • micro: histotype adenocarcinoma, often desmoplastic